University of Maryland Medical Center

AVITA Medical Receives Best Product Award at the American Association for the Surgery of Trauma

Retrieved on: 
Monday, September 25, 2023
University of Nevada, Reno, Avita Medical, University, AVH, R Adams Cowley Shock Trauma Center, Metabolism, ASX, University of Maryland Medical Center, Equity, Assistant, Regenerative medicine, Division, Physician, Annual general meeting, Wound healing, AAST, Hospital, Medicine, Trauma

In addition to the well-attended Product Theater and Best Product award, the results of AVITA Medical’s pivotal trial for full-thickness skin defects were presented by Dr. Sharon Henry, Professor of Surgery and Director, Division of Wound Healing and Metabolism at the R Adams Cowley Shock Trauma Center at University of Maryland Medical Center.

Key Points: 
  • In addition to the well-attended Product Theater and Best Product award, the results of AVITA Medical’s pivotal trial for full-thickness skin defects were presented by Dr. Sharon Henry, Professor of Surgery and Director, Division of Wound Healing and Metabolism at the R Adams Cowley Shock Trauma Center at University of Maryland Medical Center.
  • Results of the pivotal trial were recently accepted for publication in AAST’s Journal of Trauma and Acute Care Surgery.
  • The workshop is intended to provide high school students with exposure to trauma surgery as a career path.
  • Along with three other companies, AVITA Medical proudly supported this workshop with personnel and supplies, including RECELL.

Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human

Retrieved on: 
Monday, September 25, 2023
Heart, Male, Tacrolimus, University, Heart failure, Clinical trial, EGFR, End organ damage, University of Maryland Medical Center, Research, Plasma protein binding, History, Thumbay Hospital, Maryland School, Transplant, MD, Patient, Risk, Organ transplantation, Immune system, University of Maryland School of Medicine, Kidney transplantation, Immunosuppression, CD40L, Pharmaceutical industry, Dentistry, Eledone massyae

IRVINE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that tegoprubart, the company’s investigational anti-CD40 antibody, was used as a cornerstone component of the chronic immunosuppressive regimen administered following the second-ever transplant of a genetically modified heart from a pig to a human. The procedure was completed on September 20th at University of Maryland Medical Center on a 58-year-old male suffering from heart failure.

Key Points: 
  • IRVINE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that tegoprubart, the company’s investigational anti-CD40 antibody, was used as a cornerstone component of the chronic immunosuppressive regimen administered following the second-ever transplant of a genetically modified heart from a pig to a human.
  • The procedure was completed on September 20th at University of Maryland Medical Center on a 58-year-old male suffering from heart failure.
  • “The historic procedure we conducted on our courageous patient brings us to a pivotal moment in the history of organ transplantation.
  • Strategies to better and more safely protect transplanted organs and thus increase how long they function represent a significant area of unmet need in organ transplantation.

INTERNATIONALLY RENOWNED DERMATOLOGIST AND PHYSICIAN SCIENTIST SHAWN KWATRA, MD, NAMED NEW CHAIR OF DERMATOLOGY AT THE UM SCHOOL OF MEDICINE AND CHIEF OF SERVICE OF DERMATOLOGY AT UM MEDICAL CENTER

Retrieved on: 
Monday, September 18, 2023
The New England Journal of Medicine, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Medical Affairs Bureau, Society, University of Maryland, College Park, Atopic dermatitis, Skin condition, Science, Maryland School, JAMA Dermatology, Hospital, Journal, Faculty, Prurigo nodularis, University, Physician, Service, Research, Paul Khavari, Johns Hopkins School of Medicine, Human musculoskeletal system, Knowledge, NIH, Skin, Duke University, Arthritis, Immunotherapy, FPI, University of Maryland School of Medicine, Diving Medical Advisory Council, MPH, University of Maryland Medical Center, Vinay Mohan Kwatra, UMMC, Wake Forest School of Medicine, Nature Medicine, UMMS, Joseph, Assistant professor, Pharmaceutical industry, Management, Medical device, Nursing, MD, Dermatology

Dr. Kwatra, who will begin the new role in early 2024, will hold the Joseph W. Burnett Endowed Professor and Chair in Dermatology.

Key Points: 
  • Dr. Kwatra, who will begin the new role in early 2024, will hold the Joseph W. Burnett Endowed Professor and Chair in Dermatology.
  • Dr. Kwatra joins UMSOM from Johns Hopkins University School of Medicine, where he served as the Founding Director of the Johns Hopkins Itch Center.
  • "It is an honor to be the next Chair of Dermatology at such a prestigious medical school," said Kwatra.
  • He earned his undergraduate degree from Duke University and his medical degree from Wake Forest University School of Medicine.

CellMax Life Appoints Dr. Ross D. "Rusty" Segan to Advisory Board

Retrieved on: 
Wednesday, August 2, 2023
Minimally invasive procedure, University, CRC, Gastroenterology, Cancer, Tripler Army Medical Center, Olympus Corporation, Medicine, Science, Medtronic, University of Maryland Medical Center, United States Department of the Army, Adenoma, Colonoscopy, Johnson & Johnson, Injury, Vaccine, Medical device

SUNNYVALE, Calif., Aug. 2, 2023 /PRNewswire-PRWeb/ -- CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer (CRC) screening blood test, that also detects pre-cancerous polyps, or adenomas, today announced the appointment of Dr. Ross D. Segan as an advisory board member.

Key Points: 
  • CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer (CRC) screening blood test, that also detects pre-cancerous polyps, or adenomas, today announced the appointment of Dr. Ross D. Segan as an advisory board member.
  • SUNNYVALE, Calif., Aug. 2, 2023 /PRNewswire-PRWeb/ -- CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer (CRC) screening blood test, that also detects pre-cancerous polyps, or adenomas, today announced the appointment of Dr. Ross D. Segan as an advisory board member.
  • "Rusty is a visionary in aligning science, medicine and technology, bringing innovations that are clinically relevant into real-life healthcare settings," said Atul Sharan, CEO of CellMax Life.
  • For more information about CellMax Life and its FirstSight test, visit cellmaxlife.com .

The Silverstein Foundation Launches Post-Doctoral Fellowship Program to Fund Novel Research for Parkinson’s Disease in GBA Mutation Carriers

Retrieved on: 
Thursday, July 20, 2023
Research, Neurology, Philanthropy, Biotechnology, Health, Fund Raising, Foundation, Other Science, Science, Private equity, University, OrbiMed, Associate professor, Stanford University, GBA, Silverstein, Mutation, Partner (business rank), Doctor of Philosophy, Genetics, University of Maryland Medical Center, Publication, Tel Aviv Sourasky Medical Center, MD, McGill University, Hospital, Mount Sinai Health System, University of Oxford, Management, Pharmaceutical industry, Brigham, Northwestern University

The Silverstein Foundation for Parkinson’s with GBA (“Silverstein Foundation”) today announced the creation of a two-year, post-doctoral fellowship program that will fund eleven scientists engaged in cutting-edge research on Parkinson’s disease in GBA mutation carriers (GBA-PD) in academic and hospital-based laboratories around the world.

Key Points: 
  • The Silverstein Foundation for Parkinson’s with GBA (“Silverstein Foundation”) today announced the creation of a two-year, post-doctoral fellowship program that will fund eleven scientists engaged in cutting-edge research on Parkinson’s disease in GBA mutation carriers (GBA-PD) in academic and hospital-based laboratories around the world.
  • “The goal of this two-year program is to fund the next generation of elite researchers who will devote their time to finding novel, diverse approaches to analyze, prevent and treat GBA-PD,” said Jonathan Silverstein, founder of the Silverstein Foundation and a retired Managing Partner and former Co-Head of Private Equity at OrbiMed.
  • Silverstein added, “These researchers will meet regularly to collaborate and share findings with each other.
  • Furthermore, these findings will be made public to the broader GBA-PD community through publications and presentations at scientific conferences worldwide.

Dr. Jose Garcia Joins Memorial Cardiac and Vascular Institute

Retrieved on: 
Wednesday, July 12, 2023
Heart, United Network for Organ Sharing, Indiana University, University, Memorial Hermann Health System, Surgery, Harvard University, Cardiovascular disease, ECMO, Funding of science, Research, University of Maryland Medical Center, MD, Patient, Memorial, Overmyer Network, Surgeon, Kidney transplantation, Consumer, UNOS, Federation, Methodist Hospital, Massachusetts General Hospital, MCS, Dentistry, Nursing, Medical device

HOLLYWOOD, Fla., July 12, 2023 /PRNewswire-PRWeb/ -- Jose P. Garcia, MD, a Harvard-educated and fellowship-trained cardiothoracic surgeon, has been named Chief of the Adult Heart Transplant Surgery and Mechanical Circulatory Support programs at Memorial Healthcare System. A longtime educator, Garcia has held leadership positions at multiple institutions, including Indiana University (Methodist Hospital), Harvard University (Massachusetts General Hospital), and the University of Maryland Medical Center.

Key Points: 
  • "Memorial's Cardiac and Vascular Institute is one of only two facilities in South Florida performing adult heart transplants and is known to deliver excellent outcomes.
  • At Memorial's Cardiac and Vascular Institute, Dr. Garcia will pair with Dr. I-wen Wang , the Surgical Chief of ECMO services.
  • The Memorial Cardiac & Vascular Institute is a cardiovascular care leader, offering a wide array of services dedicated to the prevention, detection, and treatment of cardiovascular disease.
  • With its extraordinary medical expertise, advanced technology, and exacting quality guidelines, Memorial Cardiac & Vascular Institute has earned a reputation for superior cardiovascular care.

Final Days to Register: 5 Day Cardiac Environmental Misadventures Conference with Focus on Unfortunate Misdiagnoses (Florida, United States - July 24-28, 2023)

Retrieved on: 
Monday, July 3, 2023
Maryland School, Boarding, Hospital, Emergency medicine, University, Assistant professor, University of Maryland Medical Center, University of Maryland School of Medicine, Flour, Hyperthermia

7:30-8:30 - One Hot Mess: Resuscitating Hyperthermia (Falat) 8:30-8:40 - Break

Key Points: 
  • 7:30-8:30 - One Hot Mess: Resuscitating Hyperthermia (Falat) 8:30-8:40 - Break
    11:00-12:00 - Point/Counterpoint - Intrepid Intubations - What's Ideal?
  • (Butler, Gatz)
    11:00-12:00 - Point/Counterpoint - Battling Boarding - ED vs Hospital (Falat, Gatz)
    Assistant Professor, Department of Emergency Medicine, University of Maryland School of Medicine; Assistant Medical Director, Adult Emergency Department, University of Maryland Medical Center

BioHub Maryland Adds Alexandra Haarich as Workforce Development & Partnerships Manager

Retrieved on: 
Thursday, June 29, 2023
Research, Biotechnology, Other Health, Continuing, Training, Health, Other Science, Science, Education, Bachelor of Science in Human Biology, University, University of Maryland Medical Center, Multimedia, Towson University, Workforce, Workforce development, Marylanders, GED, Partnership, Chan Zuckerberg Biohub, Child life specialist, Management, Nursing

BioHub Maryland, an initiative to accelerate life sciences in Maryland for companies and career-seekers, has named Alexandra Haarich Manager of Workforce Development & Partnerships.

Key Points: 
  • BioHub Maryland, an initiative to accelerate life sciences in Maryland for companies and career-seekers, has named Alexandra Haarich Manager of Workforce Development & Partnerships.
  • BioHub Maryland also helps life sciences companies by showcasing career opportunities, training new life sciences talent, and providing resources for raising capital.
  • As Workforce Development and Partnerships Manager, Haarich will oversee the development of BioHub Maryland’s biopharma skills training programs and partnerships with civic organizations, industry, and academia.
  • “I am honored to join BioHub Maryland and help residents of all backgrounds find their future in life sciences,” said Haarich.

Dr. Joseph Forbess Joins Nicklaus Children's as Chief of Cardiovascular Surgery

Retrieved on: 
Wednesday, June 28, 2023
Duke University Hospital, Boston Children's Hospital, Ventricular septal defect, University, CV, University of Maryland Medical System, Isenberg School of Management, American Heart Association, Society of Thoracic Surgeons, American College of Cardiology, English, University of Texas at Austin, Research, American College of Surgeons, University of Maryland Medical Center, U.S. News & World Report, University of Maryland School of Medicine, Harvard Medical School, Cardiothoracic surgery, University of Ottawa Heart Institute, Maryland School, Hospital, Patient, NCPS, Child, Pediatrics, Society, General surgery, Growth, American College, Trauma, Elective surgery, News, Nursing, Dentistry, Nicklaus Children's Hospital, Cardiology

MIAMI, June 28, 2023 /PRNewswire/ -- Renowned pediatric cardiovascular surgeon Dr. Joseph M. Forbess has joined Nicklaus Children's Pediatric Specialists (NCPS) as chief of the Section of Cardiovascular (CV) Surgery, and assumes a leadership position within the Nicklaus Children's Heart Institute.

Key Points: 
  • MIAMI, June 28, 2023 /PRNewswire/ -- Renowned pediatric cardiovascular surgeon Dr. Joseph M. Forbess has joined Nicklaus Children's Pediatric Specialists (NCPS) as chief of the Section of Cardiovascular (CV) Surgery, and assumes a leadership position within the Nicklaus Children's Heart Institute.
  • Dr. Forbess will lead the Nicklaus Children's Heart Institute in collaboration with Dr. Lourdes Prieto, chief of the Section of Cardiology, with support from Dr. Burke.
  • Nicklaus Children's is ranked among the nation's best hospitals for pediatric cardiology and heart surgery by U.S. News & World Report.
  • Dr. Burke has been an instrumental leader in Nicklaus Children's Cardiovascular Surgery program, having helped the team and the program attain national notoriety.

Can't Misses in Emergency Medicine Conference: Cardiac Misfortunes / Environmental Misadventures / Unfortunate Misdiagnoses (New York, United States - October 16-20, 2023) - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 7, 2023
Health, Cardiology, Maryland School, Boarding, Hospital, Emergency medicine, University, Assistant professor, University of Maryland Medical Center, University of Maryland School of Medicine, Flour, Hyperthermia

7:30-8:30 - One Hot Mess: Resuscitating Hyperthermia (Falat) 8:30-8:40 - Break

Key Points: 
  • 7:30-8:30 - One Hot Mess: Resuscitating Hyperthermia (Falat) 8:30-8:40 - Break
    11:00-12:00 - Point/Counterpoint - Intrepid Intubations - What's Ideal?
  • (Butler, Gatz)
    11:00-12:00 - Point/Counterpoint - Battling Boarding - ED vs Hospital (Falat, Gatz)
    Assistant Professor, Department of Emergency Medicine, University of Maryland School of Medicine; Assistant Medical Director, Adult Emergency Department, University of Maryland Medical Center